• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找恢复肌球蛋白轻链 1 基因突变所致先天性肌病收缩功能的靶点。

Looking for Targets to Restore the Contractile Function in Congenital Myopathy Caused by GlnPro Tropomyosin.

机构信息

Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Av., 194064 St. Petersburg, Russia.

Department of Biophysics, Faculty of Biology, Saint Petersburg State University, 7/9 Universitetskaya Emb., 199034 St. Petersburg, Russia.

出版信息

Int J Mol Sci. 2020 Oct 14;21(20):7590. doi: 10.3390/ijms21207590.

DOI:10.3390/ijms21207590
PMID:33066566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7589864/
Abstract

We have used the technique of polarized microfluorimetry to obtain new insight into the pathogenesis of skeletal muscle disease caused by the GlnPro substitution in β-tropomyosin (Tpm2.2). The spatial rearrangements of actin, myosin and tropomyosin in the single muscle fiber containing reconstituted thin filaments were studied during simulation of several stages of ATP hydrolysis cycle. The angular orientation of the fluorescence probes bound to tropomyosin was found to be changed by the substitution and was characteristic for a shift of tropomyosin strands closer to the inner actin domains. It was observed both in the absence and in the presence of troponin, Ca and myosin heads at all simulated stages of the ATPase cycle. The mutant showed higher flexibility. Moreover, the GlnPro substitution disrupted the myosin-induced displacement of tropomyosin over actin. The irregular positioning of the mutant tropomyosin caused premature activation of actin monomers and a tendency to increase the number of myosin cross-bridges in a state of strong binding with actin at low Ca.

摘要

我们使用偏振微荧光技术深入了解了β-原肌球蛋白(Tpm2.2)中的 GlnPro 取代引起的骨骼肌疾病的发病机制。在模拟 ATP 水解循环的几个阶段期间,研究了含有重组细肌丝的单个肌纤维中肌动蛋白、肌球蛋白和原肌球蛋白的空间重排。发现与原肌球蛋白结合的荧光探针的角取向因取代而发生变化,并且特征是原肌球蛋白链向更靠近肌动蛋白内部结构域的方向移动。在缺乏肌钙蛋白、Ca 和肌球蛋白头部的情况下以及在模拟 ATP 酶循环的所有阶段都观察到了这种情况。突变体显示出更高的柔韧性。此外,GlnPro 取代破坏了肌球蛋白诱导的原肌球蛋白在肌动蛋白上的位移。突变体原肌球蛋白的不规则定位导致肌动蛋白单体过早激活,并倾向于在低 Ca 下增加与肌动蛋白强烈结合的肌球蛋白交联的数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/9579c62d701b/ijms-21-07590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/7da7de79d8d0/ijms-21-07590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/13f151451546/ijms-21-07590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/431393b7b4cc/ijms-21-07590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/9579c62d701b/ijms-21-07590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/7da7de79d8d0/ijms-21-07590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/13f151451546/ijms-21-07590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/431393b7b4cc/ijms-21-07590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c741/7589864/9579c62d701b/ijms-21-07590-g004.jpg

相似文献

1
Looking for Targets to Restore the Contractile Function in Congenital Myopathy Caused by GlnPro Tropomyosin.寻找恢复肌球蛋白轻链 1 基因突变所致先天性肌病收缩功能的靶点。
Int J Mol Sci. 2020 Oct 14;21(20):7590. doi: 10.3390/ijms21207590.
2
The reason for the low Ca-sensitivity of thin filaments associated with the Glu41Lys mutation in the TPM2 gene is "freezing" of tropomyosin near the outer domain of actin and inhibition of actin monomer switching off during the ATPase cycle.与 TPM2 基因突变的 Glu41Lys 相关的细肌丝钙敏感性降低的原因是肌球蛋白位于肌动蛋白外域附近的原肌球蛋白“冻结”,并在 ATP 酶循环过程中抑制肌动球蛋白单体的关闭。
Biochem Biophys Res Commun. 2018 Jul 12;502(2):209-214. doi: 10.1016/j.bbrc.2018.05.145. Epub 2018 May 26.
3
Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.导致肌病的Q147P TPM2突变使原肌球蛋白链进一步向开放位置移动,并在ATP酶循环过程中增加强结合横桥的比例。
Biochim Biophys Acta. 2016 Mar;1864(3):260-267. doi: 10.1016/j.bbapap.2015.12.004. Epub 2015 Dec 17.
4
Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.TPM3 基因 R168H 突变导致的肌收缩性失调的分子机制及其治疗药物的缓解作用。
Int J Mol Sci. 2023 Mar 18;24(6):5829. doi: 10.3390/ijms24065829.
5
The reason for a high Ca-sensitivity associated with Arg91Gly substitution in TPM2 gene is the abnormal behavior and high flexibility of tropomyosin during the ATPase cycle.TPM2基因中与精氨酸91甘氨酸替代相关的高钙敏感性的原因是原肌球蛋白在ATP酶循环过程中的异常行为和高灵活性。
Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):681-686. doi: 10.1016/j.bbrc.2017.10.161. Epub 2017 Oct 31.
6
The molecular mechanisms of a high Ca-sensitivity and muscle weakness associated with the Ala155Thr substitution in Tpm3.12.与 Tpm3.12 中的 Ala155Thr 取代相关的高钙敏感性和肌肉无力的分子机制。
Biochem Biophys Res Commun. 2019 Jul 23;515(2):372-377. doi: 10.1016/j.bbrc.2019.05.146. Epub 2019 May 30.
7
Mutations Q93H and E97K in Disrupt Ca-Dependent Regulation of Actin Filaments.突变 Q93H 和 E97K 破坏了钙依赖性对肌动蛋白丝的调节。
Int J Mol Sci. 2021 Apr 14;22(8):4036. doi: 10.3390/ijms22084036.
8
Aberrant movement of β-tropomyosin associated with congenital myopathy causes defective response of myosin heads and actin during the ATPase cycle.与先天性肌病相关的β-原肌球蛋白异常运动导致肌球蛋白头部和肌动蛋白在ATP酶循环过程中的反应缺陷。
Arch Biochem Biophys. 2015 Jul;577-578:11-23. doi: 10.1016/j.abb.2015.05.002. Epub 2015 May 13.
9
The primary cause of muscle disfunction associated with substitutions E240K and R244G in tropomyosin is aberrant behavior of tropomyosin and response of actin and myosin during ATPase cycle.与原肌球蛋白中的 E240K 和 R244G 取代相关的肌肉功能障碍的主要原因是原肌球蛋白的异常行为以及肌动蛋白和肌球蛋白在 ATP 酶循环中的反应。
Arch Biochem Biophys. 2018 Apr 15;644:17-28. doi: 10.1016/j.abb.2018.03.002. Epub 2018 Mar 3.
10
Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.TPM3.12 蛋白 R90P 突变导致的肌肉收缩失调的分子机制以及 BDM 和 W7 的这种效应的减弱。
Int J Mol Sci. 2021 Jun 12;22(12):6318. doi: 10.3390/ijms22126318.

引用本文的文献

1
Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.肌病和肌肉萎缩症的综合治疗方法:分子机制、诊断及未来疗法
Int J Mol Sci. 2025 Aug 18;26(16):7972. doi: 10.3390/ijms26167972.
2
The Twisting and Untwisting of Actin and Tropomyosin Filaments Are Involved in the Molecular Mechanisms of Muscle Contraction, and Their Disruption Can Result in Muscle Disorders.肌动蛋白丝和原肌球蛋白丝的扭转和解扭参与肌肉收缩的分子机制,它们的破坏会导致肌肉疾病。
Int J Mol Sci. 2025 Jul 12;26(14):6705. doi: 10.3390/ijms26146705.
3
Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.

本文引用的文献

1
Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.与 Tpm3.12 中的 E173A 突变相关的肌肉无力的分子机制。肌钙蛋白 Ca 敏感性抑制剂 W7 可以减轻这种突变的破坏性影响。
Int J Mol Sci. 2020 Jun 22;21(12):4421. doi: 10.3390/ijms21124421.
2
Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development.遗传性神经肌肉疾病的诊断进展及其对治疗开发的影响。
Lancet Neurol. 2020 Jun;19(6):522-532. doi: 10.1016/S1474-4422(20)30028-4. Epub 2020 May 26.
3
The molecular mechanism of muscle dysfunction associated with the R133W mutation in Tpm2.2.
TPM3 基因 R168H 突变导致的肌收缩性失调的分子机制及其治疗药物的缓解作用。
Int J Mol Sci. 2023 Mar 18;24(6):5829. doi: 10.3390/ijms24065829.
4
A pathogenic mechanism associated with myopathies and structural birth defects involves TPM2-directed myogenesis.与肌病和结构出生缺陷相关的致病机制涉及 TPM2 指导的成肌发生。
JCI Insight. 2022 Jun 22;7(12):e152466. doi: 10.1172/jci.insight.152466.
5
Editorial for Special Issue "Genetic Basis and Epidemiology of Myopathies".专刊编辑寄语:肌肉疾病的遗传学基础与流行病学研究
Int J Mol Sci. 2021 Feb 22;22(4):2152. doi: 10.3390/ijms22042152.
与 Tpm2.2 中的 R133W 突变相关的肌肉功能障碍的分子机制。
Biochem Biophys Res Commun. 2020 Feb 26;523(1):258-262. doi: 10.1016/j.bbrc.2019.12.061. Epub 2019 Dec 19.
4
The mechanism of thin filament regulation: Models in conflict?细肌丝调节机制:模型冲突?
J Gen Physiol. 2019 Nov 4;151(11):1265-1271. doi: 10.1085/jgp.201912446. Epub 2019 Sep 30.
5
Thin filament dysfunctions caused by mutations in tropomyosin Tpm3.12 and Tpm1.1.由原肌球蛋白 Tpm3.12 和 Tpm1.1 突变引起的细肌丝功能障碍。
J Muscle Res Cell Motil. 2020 Mar;41(1):39-53. doi: 10.1007/s10974-019-09532-y. Epub 2019 Jul 3.
6
Nemaline myopathies: a current view.先天性肌营养不良症:现状观点。
J Muscle Res Cell Motil. 2019 Jun;40(2):111-126. doi: 10.1007/s10974-019-09519-9. Epub 2019 Jun 21.
7
The molecular mechanisms of a high Ca-sensitivity and muscle weakness associated with the Ala155Thr substitution in Tpm3.12.与 Tpm3.12 中的 Ala155Thr 取代相关的高钙敏感性和肌肉无力的分子机制。
Biochem Biophys Res Commun. 2019 Jul 23;515(2):372-377. doi: 10.1016/j.bbrc.2019.05.146. Epub 2019 May 30.
8
Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding.原肌球蛋白相关的先天性肌病突变通过改变肌动蛋白亲和力和原肌球蛋白结合来破坏调节功能。
FEBS J. 2019 May;286(10):1877-1893. doi: 10.1111/febs.14787. Epub 2019 Mar 5.
9
Structural and functional properties of αβ-heterodimers of tropomyosin with myopathic mutations Q147P and K49del in the β-chain.肌病相关突变 Q147P 和 K49del 在β链中导致原肌球蛋白 αβ-异二聚体的结构和功能性质改变。
Biochem Biophys Res Commun. 2019 Jan 15;508(3):934-939. doi: 10.1016/j.bbrc.2018.12.019. Epub 2018 Dec 10.
10
The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.与 Tpm3.12 点突变相关的肌肉功能障碍的主要原因;突变蛋白的构象分析作为肌病分类的工具。
Int J Mol Sci. 2018 Dec 10;19(12):3975. doi: 10.3390/ijms19123975.